Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,774 | -16,764 | -10,341 | -5,320 | -22,215 |
| Depreciation Amortization | 524 | 387 | 254 | 125 | 447 |
| Other Working Capital | 1,690 | -683 | -974 | -823 | -1,103 |
| Other Operating Activity | 1,694 | 1,246 | 835 | 376 | 1,254 |
| Operating Cash Flow | $-20,866 | $-15,814 | $-10,226 | $-5,642 | $-21,617 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -133 | -133 | -65 | -4 | -253 |
| Investing Cash Flow | $-133 | $-133 | $-65 | $-4 | $-253 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -85 | -63 | -42 | -21 | -460 |
| Common Stock Issued | 35,306 | 34,483 | 28,686 | 14,361 | 76,636 |
| Financing Cash Flow | $35,221 | $34,420 | $28,644 | $14,340 | $76,176 |
| Beginning Cash Position | 63,999 | 63,999 | 63,999 | 63,999 | 9,693 |
| End Cash Position | 78,221 | 82,472 | 82,352 | 72,693 | 63,999 |
| Net Cash Flow | $14,222 | $18,473 | $18,353 | $8,694 | $54,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,866 | -15,814 | -10,226 | -5,642 | -21,617 |
| Capital Expenditure | -133 | -133 | -65 | -4 | -253 |
| Free Cash Flow | -20,999 | -15,947 | -10,291 | -5,646 | -21,870 |